高级检索
当前位置: 首页 > 详情页

Serum and xeno-free, chemically defined, no-plate-coating-based culture system for mesenchymal stromal cells from the umbilical cord

文献详情

资源类型:
WOS体系:
Pubmed体系:

收录情况: ◇ SCIE

单位: [1]Department of pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China [2]Department of Technology, Beijing JingMeng Stem Cell Technology. Co. Ltd., Beijing, China [3]Beijing Institute of Life Science Translational Medicine Research Center, Beijing, China [4]Center for Tissue Engineering and Technology of Inner Mongolia, Hohhot, Inner Mongolia, China
出处:
ISSN:

摘要:
ObjectivesUmbilical cord mesenchymal stromal cells (UCMSCs) can be considered to become a new gold standard for MSC-based therapies. A serum and xeno-free, chemically defined and no-plate-coating-based culture system will greatly facilitate development of robust, clinically acceptable bioprocesses for reproducibly generating quality-assured UCMSCs. Materials and methodsIn this study, we report for the first time, such a serum-free, xeno-free, completely chemically defined and no-plate-coating-based culture system for the isolation and expansion of UCMSCs, whose biological characteristics were evaluated and compared with serum-containing medium (SCM) methods. ResultsThis culture system not only supported UCMSC primary cultures but also allowed for their expansion at low seeding density. Compared to SCM, UCMSCs in SFM exhibited (i) higher proliferative and colony-forming capacities; (ii) distinctly different morphologies; (iii) similar phenotype; (iv) similar pluripotency-associated marker expression; (v) superior osteogenic, but reduced adipogenic differentiation capacitities. In addition, UCMSCs cultured in SFM retained similar immunomodulatory properties to those in SCM. ConclusionsOur findings demonstrate the feasibility of isolating and expanding UCMSCs in a completely serum-free, xeno-free, chemically defined and no-plate-coating-based culture system and represent an important step forward for development of robust, clinically acceptable bioprocesses for UCMSCs. Further, this provides a superior study platform for UCMSCs biology in a controlled environment.

基金:
语种:
被引次数:
WOS:
PubmedID:
中科院(CAS)分区:
出版当年[2015]版:
大类 | 3 区 生物
小类 | 4 区 细胞生物学
最新[2025]版:
大类 | 1 区 生物学
小类 | 1 区 细胞生物学
JCR分区:
出版当年[2014]版:
Q3 CELL BIOLOGY
最新[2023]版:
Q2 CELL BIOLOGY

影响因子: 最新[2023版] 最新五年平均[2021-2025] 出版当年[2014版] 出版当年五年平均[2010-2014] 出版前一年[2013版] 出版后一年[2015版]

第一作者:
第一作者单位: [1]Department of pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China [2]Department of Technology, Beijing JingMeng Stem Cell Technology. Co. Ltd., Beijing, China
通讯作者:
通讯机构: [1]Department of pharmacy, Beijing Friendship Hospital, Capital Medical University, Beijing, China [*1]Department of pharmacy, Beijing Friendship Hospital, Capital Medical University, No. 95, Yongan Road, 100050 and Beijing, China.
推荐引用方式(GB/T 7714):
APA:
MLA:

资源点击量:1320 今日访问量:0 总访问量:816 更新日期:2025-04-01 建议使用谷歌、火狐浏览器 常见问题

版权所有:重庆聚合科技有限公司 渝ICP备12007440号-3 地址:重庆市两江新区泰山大道西段8号坤恩国际商务中心16层(401121)